Research & Clinical Trials > Featured Research

Click on the “Search Now” button to search for research studies enrolling people like you. Need help getting started? Click on “Tips for Searching Studies” to find resources and assistance to help you find studies.

Survey about Endometrial Cancer Risk and Risk-Reducing Surgery for Women with a BRCA1/2 Mutation or Mutation in the Family

Survey about Endometrial Cancer Risk and Risk-Reducing Surgery for Women with a BRCA1/2 Mutation or Mutation in the Family

Surveys, Registries, Interviews
Women with a BRCA mutation OR from a family with a BRCA mutation

PARP inhibitor (niraparib) in patients with inherited or tumor PALB2 mutations in advanced solid tumors (PAVO)

PARP inhibitor (niraparib) in patients with inherited or tumor PALB2 mutations in advanced solid tumors (PAVO)

Clinicaltrials.gov identifier:
NCT05169437

Treatment
Any advanced or metastatic solid tumor except ovarian or prostate

Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)

Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)

Clinicaltrials.gov identifier:
NCT05129605

Prevention
People at high risk for prostate cancer due to an inherited mutation

BRCA 1 and 2: Interviews on Genetic Testing and Individual Experiences

BRCA 1 and 2: Interviews on Genetic Testing and Individual Experiences

Surveys, Registries, Interviews
People with or without cancer who have had or are considering BRCA testing

UCLA Research Study: Zoom Interviews to Learn from Asian Americans Living with Metastatic Cancer

UCLA Research Study: Zoom Interviews to Learn from Asian Americans Living with Metastatic Cancer

Surveys, Registries, Interviews
Asian Americans with metastatic cancer of any type

A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People with Advanced Pancreatic Cancer and BRCA Mutations

A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People with Advanced Pancreatic Cancer and BRCA Mutations

Clinicaltrials.gov identifier:
NCT04150042

Treatment
Advanced pancreatic cancer in people with a BRCA1 or BRCA2 mutation

Interview Study: Exploring Gender Diverse Experiences of Hereditary Cancer Risk

Interview Study: Exploring Gender Diverse Experiences of Hereditary Cancer Risk

Surveys, Registries, Interviews
People with elevated cancer risk who identify as trans* or nonbinary

Combination ATR inhibitor and PARP Inhibitor in Recurrent Ovarian Cancer (CAPRI)

Combination ATR inhibitor and PARP Inhibitor in Recurrent Ovarian Cancer (CAPRI)

Clinicaltrials.gov identifier:
NCT03462342

Treatment
Recurrent ovarian cancer

Treating Early-Stage BRCA, or PALB2-Associated Breast Cancer with a PARP Inhibitor (Niraparib) and Immunotherapy (Dostarlimab)

Treating Early-Stage BRCA, or PALB2-Associated Breast Cancer with a PARP Inhibitor (Niraparib) and Immunotherapy (Dostarlimab)

Clinicaltrials.gov identifier:
NCT04584255

Treatment
Early-stage breast cancer & a BRCA1, BRCA2 or PALB2 mutation

ATR Inhibitor Plus Niraparib Study in Advanced Solid Tumors and Ovarian Cancer

ATR Inhibitor Plus Niraparib Study in Advanced Solid Tumors and Ovarian Cancer

Clinicaltrials.gov identifier:
NCT04267939

Treatment
Advanced ovarian cancer or other solid tumors

Survey: Making Decisions about Genetic Testing

Survey: Making Decisions about Genetic Testing

Surveys, Registries, Interviews
Survey for adults who have had genetic testing for inherited cancer risk through a doctor

A Survey on Health Behaviors for Women with BRCA1/2 Mutations

A Survey on Health Behaviors for Women with BRCA1/2 Mutations

Surveys, Registries, Interviews
Survey for women with a BRCA1 or BRCA2 mutation

Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation

Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation

Clinicaltrials.gov identifier:
NCT04548752

Treatment
Metastatic pancreatic cancer and a BRCA1 or BRCA2 mutation

Survey: Medical Records to Save After a Cancer Diagnosis

Survey: Medical Records to Save After a Cancer Diagnosis

Surveys, Registries, Interviews
Adults with cancer

Studying Crowdfunding for Cancer

Studying Crowdfunding for Cancer

Surveys, Registries, Interviews
Cancer survivors who have used crowdfunding to help cover cancer-related costs

Tools To Be Fit: Tools to Improve Nutrition and Physical Activity for Colorectal Cancer Survivors

Tools To Be Fit: Tools to Improve Nutrition and Physical Activity for Colorectal Cancer Survivors

Clinicaltrials.gov identifier:
NCT05056077

Quality of Life
Nonmetastatic colon or rectal cancer

Investigating BRCA Previvors’ Utilization of Social Media for Health Decision Making and Social Support

Investigating BRCA Previvors’ Utilization of Social Media for Health Decision Making and Social Support

Surveys, Registries, Interviews
Women with a BRCA1 or BRCA2 mutation who have never had cancer

Testing  a Vaccine for Cancer Prevention in People with a BRCA1 or BRCA2 Mutation

Testing a Vaccine for Cancer Prevention in People with a BRCA1 or BRCA2 Mutation

Clinicaltrials.gov identifier:
NCT04367675

Prevention
People with a BRCA1 or BRCA2 mutation

A National Survey to Share the Voices of Ovarian Cancer Caregivers

A National Survey to Share the Voices of Ovarian Cancer Caregivers

Surveys, Registries, Interviews
Caregivers to people with ovarian cancer

Treatment with ATR Inhibitor for Advanced or Metastatic Solid Tumors

Treatment with ATR Inhibitor for Advanced or Metastatic Solid Tumors

Clinicaltrials.gov identifier:
NCT04657068

Treatment
Advanced solid tumors

Treating Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer with Chemotherapy and Rucaparib

Treating Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer with Chemotherapy and Rucaparib

Clinicaltrials.gov identifier:
NCT03337087

Treatment
Metastatic colorectal, pancreatic, gastroesophageal or biliary tract cancer

Nivolumab and Relatlimab in Advanced MSI-H Cancers Resistant to Prior PD-L1 Inhibitor

Nivolumab and Relatlimab in Advanced MSI-H Cancers Resistant to Prior PD-L1 Inhibitor

Clinicaltrials.gov identifier:
NCT03607890

Treatment
Solid tumors that are MSI-High and resistant to prior immunotherapy

Men at High Genetic Risk for Prostate Cancer

Men at High Genetic Risk for Prostate Cancer

Clinicaltrials.gov identifier:
NCT03805919

Prevention

Fear of Recurrence, Adversity, and Pain

Fear of Recurrence, Adversity, and Pain

Surveys, Registries, Interviews

Blood Markers of Early Pancreas Cancer

Blood Markers of Early Pancreas Cancer

Clinicaltrials.gov identifier:
NCT03568630

Prevention

Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117

Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117

Clinicaltrials.gov identifier:
NCT04770246

Treatment
People with advanced cancer and an inherited PTEN mutation

COVID-19 Breast Cancer Care Survey

COVID-19 Breast Cancer Care Survey

Surveys, Registries, Interviews

Metastatic Prostate Cancer Project

Metastatic Prostate Cancer Project

Surveys, Registries, Interviews

The Metastatic Breast Cancer Project

The Metastatic Breast Cancer Project

Surveys, Registries, Interviews

Connect My Variant

Connect My Variant

Surveys, Registries, Interviews

Study for People with Unexpected Genetic Results

Study for People with Unexpected Genetic Results

Clinicaltrials.gov identifier:
NCT02595957

Prevention

ELLIE's Project

ELLIE's Project

Quality of Life

Find My Variant

Find My Variant

Surveys, Registries, Interviews

Pancreatic Cancer Early Detection

Pancreatic Cancer Early Detection

Clinicaltrials.gov identifier:
NCT02206360

Prevention

WISDOM Study

WISDOM Study

Clinicaltrials.gov identifier:
NCT02620852

Prevention

PROMPT

PROMPT

Clinicaltrials.gov identifier:
NCT02665195

Surveys, Registries, Interviews

Serum Folate in Patients Treated with Olaparib

Serum Folate in Patients Treated with Olaparib

Clinicaltrials.gov identifier:
NCT04024254

Treatment

Talazoparib Beyond BRCA (TBB) Trial

Talazoparib Beyond BRCA (TBB) Trial

Clinicaltrials.gov identifier:
NCT02401347

Treatment


Sponsored By:

Eisai